INTEGRATED FILING — Other than Banks



General information about company

Scrip code 531209
NSE Symbol NUCLEUS
MSEI Symbol NOTLISTED
ISIN INE096B01018
Name of Company NUCLEUS SOFTWARE EXPORTS LIMITED
Type of company Main Board
Class of security Equity
Date of start of financial year 01-Apr-2024
Date of end of financial year 31-Mar-2025
Date of board meeting when results were approved 16-May-2025
Date on which prior intimation of the meeting for considering financial results was informed to the exchange 28-Apr-2025
Description of presentation currency INR (in Actuals)
Reporting Type Quarterly
Reporting Quarter Fourth quarter
Nature of report standalone or consolidated Standalone
Whether results are audited or unaudited for the quarter ended Audited
Whether results are audited or unaudited for the Year to date for current period ended/year ended Audited
Segment Reporting Multi segment
Description of single segment
Start date and time of board meeting 16-May-2025   09:30:00
End date and time of board meeting 16-May-2025   13:40:00
Whether cash flow statement is applicable on company Yes
Type of cash flow statement Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion
Whether the company has any related party? Yes
Whether the company has entered into any Related Party transaction during the selected half year for which it wants to submit disclosure? Yes
(I) We declare that the acceptance of fixed deposits by the bans/Non-Banking Finance Company are at the terms uniformly applicable/offered to all shareholders/public NA
(II) We declare that the scheduled commercial bank, as per RBI circular RBI/DBR/2015-16/19 dated March 03, 2016, has allowed additional interest of one per cent per annum, over and above the rate of interest mentioned in the schedule of interest rates on savings or a term deposits of banks staff and their exclusive associations as well as on deposits of Chairman, Chairman & Managing Director, Executive Director or such other Executives appointed for a fixed tenure. NA
(III) Whether the company is a high value debt listed entity according to regulation 15 (1A)? No
(a) If answer to above question is Yes, whether complying with proviso to regulation 23 (9), i.e., submitting RPT disclosures on the day of results publication?
(b) If answer to above question is No, please explain the reason for not complying.
Whether the updated Related Party Transactions (RPT) Policy (in compliance with Reg. 23 of SEBI LODR) has been uploaded on the website of the Company? Yes
Latest Date on which RPT policy is updated 2025-01-28
Indicate Company website link for updated RPT policy of the Company https://investor.nucleussoftware.com/CorporateGovernance.aspx
Whether statement on deviation or variation for proceeds of public issue, rights issue, preferential issue, qualified institutions placement etc. is applicable to the company for the current quarter? No
No. of times funds raised during the quarter
Whether the disclosure for the Default on Loans and Debt Securities is applicable to the entity? No
NOT APPLICABLE


Financial Results — Other than Bank
Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-Jan-2025 01-Apr-2024
B Date of end of reporting period 31-Mar-2025 31-Mar-2025
C Whether results are audited or unaudited Audited Audited
D Nature of report standalone or consolidated Standalone Standalone
Part I Blue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column.
1 Revenue From Operations
Revenue from operations 2129100000 7686600000
Other income 166100000 700400000
Total Income 2295200000 8387000000
2 Expenses
(a) Cost of materials consumed 0 0
(b) Purchases of stock-in-trade 0 0
(c) Changes in inventories of finished goods, work-in-progress and stock-in-trade 0 0
(d) Employee benefit expense 1067700000 4723500000
(e) Finance costs 1200000 5500000
(f) Depreciation and amortisation expense
(g) Other Expenses
1 Operating and other expenses 345200000 1361800000
Total other expenses 345200000 1361800000
Total expenses 1445700000 6229200000
3 Profit before exceptional and extraordinary items and tax
4 Exceptional items
5 Profit before extraordinary items and tax
6 Extraordinary items
7 Profit before tax 849500000 2157800000
8 Tax Expense
Current tax 195900000 455200000
Deferred tax 21600000 85000000
Total tax expenses 217500000 540200000
9 Net Profit Loss for the period from continuing operations
10 Profit (loss) from discontinuing operations before tax
11 Tax expense of discontinuing operations
12 Net profit (loss) from discontinuing operation after tax
13 Profit (loss) for period before minority interest
14 Share of profit (loss) of associates
15 Profit (loss) of minority interest
16 Net profit (Loss) for the period
17 Details of equity share capital
Paid-up equity share capital 263300000 263300000
Face value of equity share capital 10 10
18 Reserves excluding revaluation reserve 0
19 Earnings per equity share
Basic earnings (loss) per share from continuing and discontinued operations 24.01 60.93
Diluted earnings (loss) per share from continuing and discontinued operations 24.01 60.93
20 Debt equity ratio
21 Debt service coverage ratio
22 Interest service coverage ratio
23 Disclosure of notes on financial results


Remarks
20 Debt equity ratio
21 Debt service coverage ratio
22 Interest service coverage ratio


Cash flow statement — indirect
A Date of start of reporting period 01-Apr-2024
B Date of end of reporting period 31-Mar-2025
C Whether results are audited or unaudited Audited
D Nature of report standalone or consolidated Standalone
1 Statement of cash flows
Cash flows from used in operating activities
Profit before extraordinary items and tax
2 Adjustments for reconcile profit (loss)
Adjustments to profit (loss)
Adjustments for finance costs 2800000
Adjustments for depreciation and amortisation expense 138400000
Adjustments for impairment loss reversal of impairment loss recognised in profit or loss 0
Adjustments for unrealised foreign exchange losses gains 3600000
Adjustments for dividend income 4400000
Adjustments for share-based payments 0
Other adjustments for which cash effects are investing or financing cash flow 0
Other adjustments to reconcile profit (loss) 0
Other adjustments for non-cash items 10800000
Share of profit and loss from partnership firm or association of persons or limited liability partnerships 0
Total adjustments to profit (loss)
3 Adjustments for working capital
Adjustments for decrease (increase) in inventories 0
Adjustments for decrease (increase) in trade receivables
Adjustments for decrease (increase) in other current assets -48900000
Adjustments for increase (decrease) in trade payables
Adjustments for increase (decrease) in other current liabilities -96300000
Adjustments for provisions
Total adjustments for working capital
Total adjustments for reconcile profit (loss) -350600000
Net cash flows from (used in) operations 1807200000
Dividends received -39600000
Interest paid 0
Interest received 0
Income taxes paid (refund) 380800000
Other inflows (outflows) of cash 0
Net cash flows from (used in) operating activities before extraordinary items
Proceeds from extraordinary items
Payment for extraordinary items
Net cash flows from (used in) operating activities 1386800000
4 Cash flows from used in investing activities
Cash flows from losing control of subsidiaries or other businesses 0
Cash flows used in obtaining control of subsidiaries or other businesses 0
Other cash receipts from sales of equity or debt instruments of other entities 602000000
Other cash payments to acquire equity or debt instruments of other entities 0
Other cash receipts from sales of interests in joint ventures 0
Other cash payments to acquire interests in joint ventures 0
Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships 0
Cash payment for investment in partnership firm or association of persons or limited liability partnerships 0
Proceeds from sales of property plant and equipment 0
Purchase of property plant and equipment 150600000
Proceeds from sales of intangible assets 0
Purchase of intangible assets 0
Cash advances and loans made to other parties 0
Cash receipts from repayment of advances and loans made to other parties 0
Cash payments for future contracts, forward contracts, option contracts and swap contracts 0
Cash receipts from future contracts, forward contracts, option contracts and swap contracts 0
Dividends received 44000000
Interest received 24800000
Income taxes paid (refund) 0
Other inflows (outflows) of cash -652300000
Proceeds from government grants 0
Net cash flows from (used in) investing activities before extraordinary items
Proceeds from extraordinary items
Payment for extraordinary items
Net cash flows from (used in) investing activities -132100000
Cash flows from used in financing activities
Proceeds from issuing shares
Proceeds from issuing other equity instruments 0
Proceeds from issuing debentures notes bonds etc 0
Proceeds from borrowings 0
Repayments of borrowings 0
Dividends paid 334700000
Interest paid 2800000
Income taxes paid (refund) 0
Other inflows (outflows) of cash -892100000
Net cash flows from (used in) financing activities before extraordinary items
Proceeds from extraordinary items
Payment for extraordinary items
Net cash flows from (used in) financing activities -1252400000
Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes 2300000
6 Effect of exchange rate changes on cash and cash equivalents
Effect of exchange rate changes on cash and cash equivalents 3300000
Net increase (decrease) in cash and cash equivalents 5600000
Cash and cash equivalents cash flow statement at beginning of period 182900000
Cash and cash equivalents cash flow statement at end of period 188500000


Statement of Asset and Liabilities
Particulars Year ended (dd-mm-yyyy)
Date of start of reporting period 01-Apr-2024
Date of end of reporting period 31-Mar-2025
Whether results are audited or unaudited Audited
Nature of report standalone or consolidated Standalone
Equity and liabilities
1 Shareholders' funds
Share capital
Reserves and surplus
Money received against share warrants
Total shareholders' funds
2 Share application money pending allotment
3 Deferred government grants
4 Minority interest
5 Non-current liabilities
Long-term borrowings
Deferred tax liabilities (net) 155100000
Foreign currency monetary item translation difference liability account
Other long-term liabilities
Long-term provisions
Total non-current liabilities 552000000
6 Current liabilities
Short-term borrowings
Trade Payables
(A) Total outstanding dues of micro enterprises and small enterprises
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises
Total Trade payable
Other current liabilities 1982600000
Short-term provisions
Total current liabilities 2719200000
Total equity and liabilities 11104500000
Assets
1 Non-current assets
i Property, Plant and Equipment and Intangible assets
Property, Plant and Equipment 400900000
Producing properties
Intangible assets
Preproducing properties
Property, Plant and Equipment capital work-in-progress
Intangible assets under development or work-in-progress
Total Property, Plant and Equipment and Intangible assets
ii Non-current investments 4234700000
v Deferred tax assets (net) 0
vi Foreign currency monetary item translation difference asset account
vii Long-term loans and advances
viii Other non-current assets 180500000
Total non-current assets 6148000000
Current assets
Current investments 2321700000
Inventories 0
Trade receivables
Cash and cash equivalents 188500000
Bank balance other than cash and cash equivalents 722100000
Short-term loans and advances
Other current assets 412000000
Total current assets 4956500000
Total assets 11104500000
Disclosure of notes on assets and liabilities


Format for Reporting Segment wise Revenue, Results and Capital Employed along with the company results
Particulars 3 months/ 6 month ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period 01-Jan-2025 01-Apr-2024
Date of end of reporting period 31-Mar-2025 31-Mar-2025
Whether results are audited or unaudited Audited Audited
Nature of report standalone or consolidated Standalone Standalone
1 Segment Revenue (Income)
(net sale/income from each segment should be disclosed)
1 India 1359500000 4799900000
2 Far East 32700000 106300000
3 South East Asia 228500000 885800000
4 Europe 26700000 158200000
5 Middle East 250000000 914600000
6 Africa 28100000 82300000
7 Australia 74300000 244100000
8 Others 129300000 495400000
Total Segment Revenue 2129100000 7686600000
Less: Inter segment revenue 0 0
Revenue from operations 2129100000 7686600000
2 Segment Result
Profit (+) / Loss (-) before tax and interest from each segment
1 India 930400000 2928000000
2 Far East 2400000 -41600000
3 South East Asia 9300000 -73700000
4 Europe 7800000 47400000
5 Middle East 57500000 76700000
6 Africa 18900000 61100000
7 Australia 40900000 83200000
8 Others 55900000 191900000
Total Profit before tax 1123100000 3273000000
i. Finance cost 0 0
ii. Other Unallocable Expenditure net off Unallocable income 273600000 1115200000
Profit before tax 849500000 2157800000
3 (Segment Asset - Segment Liabilities)
Segment Asset
1 India 782100000 782100000
2 Far East 25600000 25600000
3 South East Asia 286100000 286100000
4 Europe 800000 800000
5 Middle East 218300000 218300000
6 Africa 37800000 37800000
7 Australia 97400000 97400000
8 Others 220900000 220900000
Total Segment Asset 1669000000 1669000000
Un-allocable Assets 9435500000 9435500000
Net Segment Asset 11104500000 11104500000
4 Segment Liabilities
Segment Liabilities
1 India 1417900000 1417900000
2 Far East 45100000 45100000
3 South East Asia 356300000 356300000
4 Europe 32200000 32200000
5 Middle East 479600000 479600000
6 Africa 29500000 29500000
7 Australia 141900000 141900000
8 Others 175900000 175900000
Total Segment Liabilities 2678400000 2678400000
Un-allocable Liabilities 592800000 592800000
Net Segment Liabilities 3271200000 3271200000
Disclosure of notes on segments




Details of Impact of Audit Qualification
Whether results are audited or unaudited Audited
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion
Auditor's opinion
Declaration pursuant to Regulation 33 (3) (d) of SEBI (LODR) Regulation, 2015: The company declares that its Statutory Auditor/s have issued an Audit Report with unmodified opinion for the period on Standalone results Yes
Sr No. Audit firm's name Whether the firm holds a valid peer review certificate issued by Peer Review Board of ICAI Certificate valid upto
1 ASA & Associates LLP Yes 31-Mar-2026


Financial details
Sr. Particulars Audited Figures (as reported before adjusting for qualifications) Adjusted Figures (audited figures after adjusting for qualifications)
1 Turnover / Total income
2 Total Expenditure
3 Net Profit/(Loss)
4 Earnings Per Share
5 Total Assets
6 Total Liabilities
7 Net Worth


Signatories details

Name of CEO / Managing director
Name of CFO
Name of audit committee chairman
Name of statutory auditor
Name of other signatory, if any, with designation
Place
Date


Signatory Details
Name of signatory
Designation of person
Place
Date


Format for Disclosure of Related Party Transactions (applicable only for half-yearly filings i.e., 2nd and 4th quarter)
Sr No. Additional disclosure of related party transactions - applicable only in case the related party transaction relates to loans, inter-corporate deposits, advances or investments made or given by the listed entity/subsidiary. These details need to be disclosed only once, during the reporting period when such transaction was undertaken.
Details of the party (listed entity /subsidiary) entering into the transaction Details of the counterparty Type of related party transaction Details of other related party transaction Value of the related party transaction as approved by the audit committee Remarks on approval by audit committee Value of transaction during the reporting period In case monies are due to either party as a result of the transaction In case any financial indebtedness is incurred to make or give loans, inter-corporate deposits, advances or investments Details of the loans, inter-corporate deposits, advances or investments Notes
Name PAN Name PAN Relationship of the counterparty with the listed entity or its subsidiary Opening balance Closing balance Nature of indebtedness (loan/ issuance of debt/ any other etc.) Details of other indebtedness Cost Tenure Nature (loan/ advance/ intercorporate deposit/ investment ) Interest Rate (%) Tenure Secured/ unsecured Purpose for which the funds will be utilised by the ultimate recipient of funds (endusage)
1 Nucleus Software Exports Limited Vishnu Rampratap Dusadttt Managing Director Remuneration 6374000 Approvedt 6374000 0 0
2 Nucleus Software Exports Limited Poonam Bhasin Company Secretary Remuneration Approvedt 0 0 0 Textual Information(1)
3 Nucleus Software Exports Limited Parag Bhisett Executive Director Remuneration Approvedt 0 0 0 Textual Information(2)
4 Nucleus Software Exports Limited Surya Prakash Kanodia Chief Financial Officer Remuneration Approved 0 0 0 Textual Information(3)
5 Nucleus Software Exports Limited Siddhartha Mahavir Acharya Non Executive Director Any other transaction Siiting Fees 1500000 Approved 0 0 0
6 Nucleus Software Exports Limited Yasmin Javeri Krishan Non Executive Director Any other transaction Siiting Fees 1500000 Approved 0 0 0
7 Nucleus Software Exports Limited Prakash Chandra Kandpalt Non Executive Director Any other transaction Siiting Fees 1600000 Approved 0 0 0
8 Nucleus Software Exports Limited Shekar Viswanathant Non Executive Director Any other transaction Siiting Fees 1000000 Approved 0 0 0
9 Nucleus Software Exports Limited Mark McCoytt Director of Wholly Owned Subsidiary Remuneration 607000 Approved 607000 0 0
10 Nucleus Software Exports Limited Anurag Mantrit Executive Director Remuneration 0 Approved 0 0 0 Textual Information(4)
11 Nucleus Software Exports Limited Nucleus Software Foundationtt CSR Foundation of the Company Any other transaction Contribution towards CSRt 13850000 Approved 13850000 0 0 Textual Information(5)
12 Nucleus Software Exports Limited Praxis Consulting and Information services Pvt Ltdtt Interested Director Purchase of goods or services 250000 Approved 250000 0 0
13 Nucleus Software Exports Limited Yasmin Javeri Krishantt Interested Director and Director of Wholly Owned Subsidiary Remuneration 1719000 Approvedt 1719000 0 0
14 Nucleus Software Exports Limited Nucleus Software Limitedt Wholly Owned Subsidiary Interest received 130000 Approvedt 130000 0 0
15 Nucleus Software Exports Limited Nucleus Software Solutions Pte Ltd, Singaporet Wholly Owned Subsidiary Sale of goods or services 153774000 Approved 153774000 0 0
16 Nucleus Software Exports Limited Nucleus Software Solutions Pte Ltd, Singaporet Wholly Owned Subsidiary Any other transaction Reimbursement of Expensest 1214000 Approved 1214000 0 0
17 Nucleus Software Exports Limited Nucleus Software Japan Kabushiki Kaisha, Japant Wholly Owned Subsidiary Any other transaction Reimbursement of Expenses 458000 Approved 458000 0 0
18 Nucleus Software Exports Limited Nucleus Software Australia Pty Ltdt Wholly Owned Subsidiary Purchase of goods or services 19282000 Approved 19282000 0 0
19 Nucleus Software Exports Limited Nucleus Software Solutions Pte Ltd, Singaporet Wholly Owned Subsidiary Any other transaction Sales & Marketing Expenses 21467000 Approved 21467000 0 0
20 Nucleus Software Exports Limited Nucleus Software Australia Pty Ltdt Wholly Owned Subsidiary Any other transaction Sales & Marketing Expenses 12556000 Approved 12556000 0 0
21 Nucleus Software Exports Limited Nucleus Software Japan Kabushiki Kaisha, Japant Wholly Owned Subsidiary Purchase of goods or services 21419000 Approved 21419000 0 0
22 Nucleus Software Exports Limited Nucleus Software Japan Kabushiki Kaisha, Japan Wholly Owned Subsidiary Any other transaction Sales & Marketing Expenses 5475000 Approved 5475000 0 0
23 Nucleus Software Exports Limited Nucleus Software Solutions Pte Ltd, Singapore Wholly Owned Subsidiary Any other transaction Reimbursement of Expenses 3549000 Approved 3549000 0 0
24 Nucleus Software Exports Limited Nucleus Software Solutions Pte Ltd, Singapore Wholly Owned Subsidiary Any other transaction Business Management Services 40742000 Approved 40742000 0 0
25 Nucleus Software Exports Limited Nucles Software Inc, USA Wholly Owned Subsidiary Any other transaction Business Consultancy Services 4795000 Approved 4795000 0 0
Total value of transaction during the reporting period 307661000



Text Block
Textual Information(1) As per 3rd amendment Regulations issued by SEBI dated December 12, 2024, Remuneration paid by the Company or its subsidiary to its Director or KMP does not require approval of Audit Committee if the same is not material in terms of Reg 23(1).Hence remuneration details are not included for quarter ended December 31, 2024 and March 31, 2025.
Textual Information(2) As per 3rd amendment Regulations issued by SEBI dated December 12, 2024, Remuneration paid by the Company or its subsidiary to its Director or KMP does not require approval of Audit Committee if the same is not material in terms of Reg 23(1).Hence remuneration details are not included for quarter ended December 31, 2024 and March 31, 2025.
Textual Information(3) As per 3rd amendment Regulations issued by SEBI dated December 12, 2024, Remuneration paid by the Company or its subsidiary to its Director or KMP does not require approval of Audit Committee if the same is not material in terms of Reg 23(1).Hence remuneration details are not included for quarter ended December 31, 2024 and March 31, 2025.
Textual Information(4) As per 3rd amendment Regulations issued by SEBI dated December 12, 2024, Remuneration paid by the Company or its subsidiary to its Director or KMP does not require approval of Audit Committee if the same is not material in terms of Reg 23(1).Hence remuneration details are not included for quarter ended December 31, 2024 and March 31, 2025.
Textual Information(5) Interested Director (Mr. Prithvi Pal Singh Haldea) has retired from the Company on July 25, 2024 after completion of his term


Format for Disclosing Outstanding Default on Loans and Debt Securities
Sr. No. Particulars Amount Remarks
1. Loans / revolving facilities like cash credit from banks / financial institutions
A Total amount outstanding as on date
B Of the total amount outstanding, amount of default as on date
2. Unlisted debt securities i.e. NCDs and NCRPS
A Total amount outstanding as on date
B Of the total amount outstanding, amount of default as on date
3. Total financial indebtedness of the listed entity including short-term and long-term debt